Cancer Research Targets Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maglione, J. E.
Right arrow Articles by MacLeod, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maglione, J. E.
Right arrow Articles by MacLeod, C. L.
[Cancer Research 61, 8298-8305, November 15, 2001]
© 2001 American Association for Cancer Research

Tumor Biology

Transgenic Polyoma Middle-T Mice Model Premalignant Mammary Disease1

Jeannie E. Maglione2, Drew Moghanaki2, Lawrence J. T. Young2, Cathyryne K. Manner, Lesley G. Ellies, Sasha O. Joseph, Benjamin Nicholson, Robert D. Cardiff2,,3 and Carol L. MacLeod2,,3

Department of Medicine, Cancer Center, School of Medicine, University of California, San Diego, La Jolla, California 92093 [J. E. M., D. M., C. K M., L. G. E., S. O. J., B. N., C. L. M.], and Center for Comparative Medicine, Schools of Medicine and Veterinary Medicine and the Department of Pathology, University of California, Davis, Davis, California 95616 [L. J. T. Y., R. D. C.]

Mice transgenic for the Polyomavirus middle T (PyV-mT) gene have been widely used to study mammary tumorigenesis and metastasis. Although numerous molecular insights were gained from the analysis of these transgenic malignant tumors, the early events leading to malignant transformation have not been systematically investigated nor has the biological potential of hyperplastic lesions been documented. This paper presents the first comprehensive histopathological characterization of transgenic PyV-mT hyperplasias together with classical transplantation experiments designed to test the growth potential of these lesions. Moreover, stable hyperplastic outgrowth lines were established as a tool to study premalignant PyV-mT-induced hyperplasias in detail. Each line has a different tumor latency, indicating that PyV-mT-induced hyperplasias, like early proliferative lesions seen in the human breast, are heterogeneous with respect to their malignant potential. Our results settle a controversy; they establish that PyV-mT gene expression alone is insufficient to induce tumors and that additional events are required for tumorigenesis and metastasis. These results support the use of PyV-mT transgenic mice as a model for investigating the multistep progression of malignant mammary tumorigenesis and metastasis.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
B. Schade, T. Rao, N. Dourdin, R. Lesurf, M. Hallett, R. D. Cardiff, and W. J. Muller
PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis
J. Biol. Chem., July 10, 2009; 284(28): 19018 - 19026.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. J. Stewart, D. J. Liewehr, S. M. Steinberg, K. M. Greeneltch, and S. I. Abrams
Modulating the Expression of IFN Regulatory Factor 8 Alters the Protumorigenic Behavior of CD11b+Gr-1+ Myeloid Cells
J. Immunol., July 1, 2009; 183(1): 117 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
F. Sotgia, M. C. Casimiro, G. Bonuccelli, M. Liu, D. Whitaker-Menezes, O. Er, K. M. Daumer, I. Mercier, A. K. Witkiewicz, C. Minetti, et al.
Loss of Caveolin-3 Induces a Lactogenic Microenvironment that Is Protective Against Mammary Tumor Formation
Am. J. Pathol., February 1, 2009; 174(2): 613 - 629.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
J. D. Kessler, H. Hasegawa, S. N. Brun, B. A. Emmenegger, Z.-J. Yang, J. W. Dutton, F. Wang, and R. J. Wechsler-Reya
N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma
Genes & Dev., January 15, 2009; 23(2): 157 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Wang, Y. Yuan, L. Liao, S.-Q. Kuang, J. C.-Y. Tien, B. W. O'Malley, and J. Xu
Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation
PNAS, January 6, 2009; 106(1): 151 - 156.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. G. Bitler, I. Menzl, C. L. Huerta, B. Sands, W. Knowlton, A. Chang, and J. A. Schroeder
Intracellular MUC1 Peptides Inhibit Cancer Progression
Clin. Cancer Res., January 1, 2009; 15(1): 100 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. P. Provenzano, D. R. Inman, K. W. Eliceiri, H. E. Beggs, and P. J. Keely
Mammary Epithelial-Specific Disruption of Focal Adhesion Kinase Retards Tumor Formation and Metastasis in a Transgenic Mouse Model of Human Breast Cancer
Am. J. Pathol., November 1, 2008; 173(5): 1551 - 1565.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Almholt, A. Juncker-Jensen, O. D. Laerum, K. Dano, M. Johnsen, L. R. Lund, and J. Romer
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model
Mol. Cancer Ther., September 1, 2008; 7(9): 2758 - 2767.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. W. Hebbard, M. Garlatti, L. J.T. Young, R. D. Cardiff, R. G. Oshima, and B. Ranscht
T-cadherin Supports Angiogenesis and Adiponectin Association with the Vasculature in a Mouse Mammary Tumor Model
Cancer Res., March 1, 2008; 68(5): 1407 - 1416.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Hulit, K. Suyama, S. Chung, R. Keren, G. Agiostratidou, W. Shan, X. Dong, T. M. Williams, M. P. Lisanti, K. Knudsen, et al.
N-Cadherin Signaling Potentiates Mammary Tumor Metastasis via Enhanced Extracellular Signal-Regulated Kinase Activation
Cancer Res., April 1, 2007; 67(7): 3106 - 3116.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. Du, K. Podsypanina, S. Huang, A. McGrath, M. J. Toneff, E. Bogoslovskaia, X. Zhang, R. C. Moraes, M. Fluck, D. C. Allred, et al.
Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models
PNAS, November 14, 2006; 103(46): 17396 - 17401.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. M. Williams, F. Sotgia, H. Lee, G. Hassan, D. Di Vizio, G. Bonuccelli, F. Capozza, I. Mercier, H. Rui, R. G. Pestell, et al.
Stromal and Epithelial Caveolin-1 Both Confer a Protective Effect Against Mammary Hyperplasia and Tumorigenesis: Caveolin-1 Antagonizes Cyclin D1 Function in Mammary Epithelial Cells
Am. J. Pathol., November 1, 2006; 169(5): 1784 - 1801.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
R. D. Cardiff, M. R. Anver, G. P. Boivin, M. W. Bosenberg, R. R. Maronpot, A. A. Molinolo, A. Y. Nikitin, J. E. Rehg, G. V. Thomas, R. G. Russell, et al.
Precancer in Mice: Animal Models Used to Understand, Prevent, and Treat Human Precancers
Toxicol Pathol, October 1, 2006; 34(6): 699 - 707.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. D. Cardiff, J. P. Gregg, J. W. Miller, D. E. Axelrod, and A. D. Borowsky
Histopathology as a Predictive Biomarker: Strengths and Limitations
J. Nutr., October 1, 2006; 136(10): 2673S - 2675S.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
G. D. Basu, T. L. Tinder, J. M. Bradley, T. Tu, C. L. Hattrup, B. A. Pockaj, and P. Mukherjee
Cyclooxygenase-2 Inhibitor Enhances the Efficacy of a Breast Cancer Vaccine: Role of IDO
J. Immunol., August 15, 2006; 177(4): 2391 - 2402.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Namba, L. J.T. Young, C. K. Abbey, L. Kim, P. Damonte, A. D. Borowsky, J. Qi, C. G. Tepper, C. L. MacLeod, R. D. Cardiff, et al.
Rapamycin Inhibits Growth of Premalignant and Malignant Mammary Lesions in a Mouse Model of Ductal Carcinoma In situ
Clin. Cancer Res., April 15, 2006; 12(8): 2613 - 2621.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Zhang, L. C. Stephens, and R. Kumar
Metastasis Tumor Antigen Family Proteins during Breast Cancer Progression and Metastasis in a Reliable Mouse Model for Human Breast Cancer
Clin. Cancer Res., March 1, 2006; 12(5): 1479 - 1486.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Cecena, F. Wen, R. D. Cardiff, and R. G. Oshima
Differential Sensitivity of Mouse Epithelial Tissues to the Polyomavirus Middle T Oncogene
Am. J. Pathol., January 1, 2006; 168(1): 310 - 320.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. I. Lopez, T. D. Camenisch, M. V. Stevens, B. J. Sands, J. McDonald, and J. A. Schroeder
CD44 Attenuates Metastatic Invasion during Breast Cancer Progression
Cancer Res., August 1, 2005; 65(15): 6755 - 6763.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
A. C. Curino, L. H. Engelholm, S. S. Yamada, K. Holmbeck, L. R. Lund, A. A. Molinolo, N. Behrendt, B. S. Nielsen, and T. H. Bugge
Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy
J. Cell Biol., June 20, 2005; 169(6): 977 - 985.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. E. Peace, K. Toney-Earley, M. H. Collins, and S. E. Waltz
Ron Receptor Signaling Augments Mammary Tumor Formation and Metastasis in a Murine Model of Breast Cancer
Cancer Res., February 15, 2005; 65(4): 1285 - 1293.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. M. Williams, F. Medina, I. Badano, R. B. Hazan, J. Hutchinson, W. J. Muller, N. G. Chopra, P. E. Scherer, R. G. Pestell, and M. P. Lisanti
Caveolin-1 Gene Disruption Promotes Mammary Tumorigenesis and Dramatically Enhances Lung Metastasis in Vivo: ROLE OF CAV-1 IN CELL INVASIVENESS AND MATRIX METALLOPROTEINASE (MMP-2/9) SECRETION
J. Biol. Chem., December 3, 2004; 279(49): 51630 - 51646.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
G. D. Basu, L. B. Pathangey, T. L. Tinder, M. LaGioia, S. J. Gendler, and P. Mukherjee
Cyclooxygenase-2 Inhibitor Induces Apoptosis in Breast Cancer Cells in an In vivo Model of Spontaneous Metastatic Breast Cancer
Mol. Cancer Res., November 1, 2004; 2(11): 632 - 642.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. A. B. Knostman, J.-Y. Cho, K.-Y. Ryu, X. Lin, J. A. McCubrey, T. Hla, C. H. Liu, E. Di Carlo, R. Keri, M. Zhang, et al.
Signaling through 3',5'-Cyclic Adenosine Monophosphate and Phosphoinositide-3 Kinase Induces Sodium/Iodide Symporter Expression in Breast Cancer
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5196 - 5203.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Zhang, S.-Q. Kuang, L. Liao, S. Zhou, and J. Xu
Haploid Inactivation of the Amplified-in-Breast Cancer 3 Coactivator Reduces the Inhibitory Effect of Peroxisome Proliferator-Activated Receptor {gamma} and Retinoid X Receptor on Cell Proliferation and Accelerates Polyoma Middle-T Antigen-Induced Mammary Tumorigenesis in Mice
Cancer Res., October 1, 2004; 64(19): 7169 - 7177.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
A. W. Cohen, R. Hnasko, W. Schubert, and M. P. Lisanti
Role of Caveolae and Caveolins in Health and Disease
Physiol Rev, October 1, 2004; 84(4): 1341 - 1379.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. K. Abbey, A. D. Borowsky, E. T. McGoldrick, J. P. Gregg, J. E. Maglione, R. D. Cardiff, and S. R. Cherry
In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia
PNAS, August 3, 2004; 101(31): 11438 - 11443.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
R. Namba, J. E. Maglione, L. J.T. Young, A. D. Borowsky, R. D. Cardiff, C. L. MacLeod, and J. P. Gregg
Molecular Characterization of the Transition to Malignancy in a Genetically Engineered Mouse-Based Model of Ductal Carcinoma In situ
Mol. Cancer Res., August 1, 2004; 2(8): 453 - 463.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J. E. Maglione, E. T. McGoldrick, L. J.T. Young, R. Namba, J. P. Gregg, L. Liu, D. Moghanaki, L. G. Ellies, A. D. Borowsky, R. D. Cardiff, et al.
Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: Single origin, divergent evolution, and multiple outcomes
Mol. Cancer Ther., August 1, 2004; 3(8): 941 - 953.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
R. D. Cardiff, A. Rosner, M. A. Hogarth, J. J. Galvez, A. D. Borowsky, and J. P. Gregg
Validation: The New Challenge for Pathology
Toxicol Pathol, January 1, 2004; 32(1_suppl): 31 - 39.
[Abstract] [PDF]

Home page
 Mol. Interv.Home page
R. Hnasko and M. P. Lisanti
The Biology of Caveolae: Lessons from Caveolin Knockout Mice and Implications for Human Disease
Mol. Interv., December 1, 2003; 3(8): 445 - 464.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. Y. Lin, J. G. Jones, P. Li, L. Zhu, K. D. Whitney, W. J. Muller, and J. W. Pollard
Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
Am. J. Pathol., November 1, 2003; 163(5): 2113 - 2126.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Xue, D. Plieth, C. Venkov, C. Xu, and E. G. Neilson
The Gatekeeper Effect of Epithelial-Mesenchymal Transition Regulates the Frequency of Breast Cancer Metastasis
Cancer Res., June 15, 2003; 63(12): 3386 - 3394.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Medina, F. S. Kittrell, A. Shepard, A. Contreras, J. M. Rosen, and J. Lydon
Hormone Dependence in Premalignant Mammary Progression
Cancer Res., March 1, 2003; 63(5): 1067 - 1072.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
T. M. Williams, M. W.-C. Cheung, D. S. Park, B. Razani, A. W. Cohen, W. J. Muller, D. Di Vizio, N. G. Chopra, R. G. Pestell, and M. P. Lisanti
Loss of Caveolin-1 Gene Expression Accelerates the Development of Dysplastic Mammary Lesions in Tumor-Prone Transgenic Mice
Mol. Biol. Cell, March 1, 2003; 14(3): 1027 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Ahmed, J. Wyckoff, E. Y. Lin, W. Wang, Y. Wang, L. Hennighausen, J.-i. Miyazaki, J. Jones, J. W. Pollard, J. S. Condeelis, et al.
GFP Expression in the Mammary Gland for Imaging of Mammary Tumor Cells in Transgenic Mice
Cancer Res., December 15, 2002; 62(24): 7166 - 7169.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Rosner, K. Miyoshi, E. Landesman-Bollag, X. Xu, D. C. Seldin, A. R. Moser, C. L. MacLeod, G. Shyamala, A. E. Gillgrass, and R. D. Cardiff
Pathway Pathology : Histological Differences Between ErbB/Ras and Wnt Pathway Transgenic Mammary Tumors
Am. J. Pathol., September 1, 2002; 161(3): 1087 - 1097.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.